Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open‐Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers
Article in Clinical Pharmacology in Drug Development (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Secondary Prevention of Systemic Arterial and Recurrent Venous Thromboembolic Events, Through Extended Time Anticoagulation with Apixaban, in an Elderly Patient with Multiple Comorbidities, Clinical Case
Article in International Archives of Medicine (January 2016)